Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Innovita Biological Technology Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥36.2 Mil. Innovita Biological Technology Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-0.1 Mil.
Innovita Biological Technology Co's interest coverage for the quarter that ended in Mar. 2026 was 669.85.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Innovita Biological Technology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Innovita Biological Technology Co's Interest Coverage or its related term are showing as below:
SHSE:688253'
s Interest Coverage Range Over the Past 10 Years
Min: 97.94 Med: 997.64 Max: 4012.23
Current: 339.75
SHSE:688253's Interest Coverage is ranked better than 56.65% of 376
companies
in the Biotechnology industry
Industry Median: 104.025
vs SHSE:688253: 339.75
Innovita Biological Technology Co (SHSE:688253) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Innovita Biological Technology Co Interest Coverage Related Terms
Innovita Biological Technology Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Innovita Biological Technology Co Interest Coverage Chart
SHSE:688253 vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Innovita Biological Technology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innovita Biological Technology Co Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Innovita Biological Technology Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Innovita Biological Technology Co's Interest Coverage falls into.
Innovita Biological Technology Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovita Biological Technology Co (SHSE:688253) has a Interest Coverage of 669.85 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Innovita Biological Technology Co and its competitors. This is 33% below median its historical median of 997.64. Over the past decade, Innovita Biological Technology Co's Interest Coverage has ranged from 97.94 to 4,012.23. According to the industry distribution chart, Innovita Biological Technology Co ranks #163 out of 376 companies in the Biotechnology industry, placing it in the top 43.4%.
Is Innovita Biological Technology Co's Interest Coverage too high?
Innovita Biological Technology Co's current Interest Coverage of 669.85 is 33% below median its 10-year median of 997.64. Over the past 10 years, this metric has ranged from a low of 97.94 to a high of 4,012.23. The Biotechnology industry median Interest Coverage is 104.03. Innovita Biological Technology Co's value of 669.85 is 543.9% above this industry median. Based on the distribution chart, Innovita Biological Technology Co ranks #163 out of 376 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Innovita Biological Technology Co has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Innovita Biological Technology Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Innovita Biological Technology Co ranks #163 out of 376 companies for Interest Coverage. This puts Innovita Biological Technology Co in the upper half of its industry. The industry median Interest Coverage is 104.03. Innovita Biological Technology Co's value of 669.85 is 543.9% above this benchmark. Historically, Innovita Biological Technology Co's own Interest Coverage has ranged from 97.94 to 4,012.23 over the past decade. While the company's 10-year median is 997.64 vs. the industry median of 104.03, Innovita Biological Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 104.03, based on 376 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innovita Biological Technology Co's current Interest Coverage of 669.85 is 543.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Innovita Biological Technology Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 104.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovita Biological Technology Co's current Interest Coverage is 669.85, which is 33% below median its own 10-year median of 997.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovita Biological Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Innovita Biological Technology Co (SHSE:688253) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥20.48, compared to a current price of ¥58.92 — trading 187.7% above its estimated fair value. The current Interest Coverage is 669.85, which is 33% below median its 10-year median of 997.64 and 543.9% above the Biotechnology industry median of 104.03. Innovita Biological Technology Co's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Innovita Biological Technology Co (SHSE:688253), the current Interest Coverage is 669.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innovita Biological Technology Co (SHSE:688253) Overvalued in 2026?
Based on GuruFocus' analysis, Innovita Biological Technology Co stock appears to be overvalued.
The current stock price of ¥58.92 is trading 187.7% above its estimated GF Value™ of ¥20.48.
GuruFocus considers Innovita Biological Technology Co to be Significantly Overvalued.
Key valuation signals for SHSE:688253:
Interest Coverage: 669.85 (33% below median its 10-year median of 997.64)
GF Value™: ¥20.48 vs. price of ¥58.92 (187.7% above fair value)
Industry Position: 543.9% above the Biotechnology median (#163 of 376)
No single metric tells the full story. See the SHSE:688253 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innovita Biological Technology Co Business Description
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production, and sales of POCT in vitro diagnostic products.
61GF Score
Get the complete analysis for SHSE:688253
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688253 has been successfully added to your 
